On March 18, 2022 EpiVax reported the 1st Annual Tregitope Summit will be held on Monday, May 16th 2022 at the The Westin Boston Seaport District (Press release, EpiVax, MAR 18, 2022, View Source [SID1234610333]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Registration is now open!

Organizing Theme: Activation of Regulatory T Cells for Induction of Immune Tolerance

Interest in therapeutics specifically for inducing and activating Tregs by various approaches including administration of Tregitopes, is growing, and we see the need for an annual meeting for academic and industry researchers to share ideas, create new collaborations and continue to expand this growing therapeutic area.

Session 1: Treg cells as therapeutics
Chair: Dr. David Scott, Uniformed Services University Health System

Session 2: Protein Therapeutics (including Tregitopes) and antigen specific approaches to Address Tolerance: Therapeutics designed to Stimulate Tregs
Chair: Dr. Amy Rosenberg, EpiVax

We encourage you to attend this unique forum. Registration link here: https://bit.ly/EpiVaxTregitopeSummit

Attending Hanson Wade’s Treg Directed Therapies? We’ve planned the Tregitope Summit for the Monday before for ease of attendance!